DOJ 'Not Done' With Generic Drug Price-Fixing
The U.S. Department of Justice is not done investigating price-fixing in the pharmaceutical industry, a high-ranking member of the agency said in a criminal antitrust enforcement speech in Miami on Friday....To view the full article, register now.
Already a subscriber? Click here to view full article